JSOM Header

Resilience and Suicide in Special Operations Forces: State of the Science via Integrative Review

Summer 2019

Kate Rocklein Kemplin, DNP, RN; Olimpia Paun, PhD, PMHCNS-BC; Dan Godbee, MD, FACEP; Jonathan Brandon, MD4

References

  1. Benjamin JM, Abo BN, Brandehoff N. Review Article: Snake Envenomation in Africa. Current Tropical Medicine Reports. January 2020. doi:10.1007/s40475-020-00198-y
  2. Chippaux J-P. Snakebite envenomation turns again into a neglected tropical disease! J Venom Anim Toxins Incl Trop Dis. 2017;23:38. doi:10.1186/s40409-017-0127-6
  3. Chippaux J-P. Incidence and mortality due to snakebite in the Americas. PLoS Negl Trop Dis. 2017;11(6):e0005662. doi:10.1371/journal.pntd.0005662
  4. Chippaux J-P. Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach. Toxicon. 2011;57(4):586-599. doi:10.1016/j.toxicon.2010.12.022
  5. Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218. doi:10.1371/journal.pmed.0050218
  6. Mohapatra B, Warrell DA, Suraweera W, et al. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl Trop Dis. 2011;5(4):e1018. doi:10.1371/journal.pntd.0001018
  7. Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063. doi:10.1038/nrdp.2017.63
  8. Habib AG, Kuznik A, Hamza M, et al. Snakebite is Under Appreciated: Appraisal of Burden from West Africa. PLoS Negl Trop Dis. 2015;9(9):e0004088. doi:10.1371/journal.pntd.0004088
  9. Longbottom J, Shearer FM, Devine M, et al. Vulnerability to snakebite envenoming: a global mapping of hotspots. Lancet. 2018;392(10148):673-684. doi:10.1016/S0140-6736(18)31224-8
  10. Williams DJ, Faiz MA, Abela-Ridder B, et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl Trop Dis. 2019;13(2):e0007059. doi:10.1371/journal.pntd.0007059
  11. Lial JP. [Health assessments of a military company stationed on the Maroni River in French Guiana]. Med Trop . 1999;59(1):95-98. https://www.ncbi.nlm.nih.gov/pubmed/10472589.
  12. Lynch JH, Verlo AR, Givens ML, Munoz CE. Bites, stings, and rigors: clinical considerations in African operations. J Spec Oper Med. 2014;14(4):113-121. https://www.ncbi.nlm.nih.gov/pubmed/25399379.
  13. Kairi JK, Lal V, Ghate JV, Nayak BB, Kotabagi RB. Poisoning and envenomation registry: analysis of 200 case reports. Armed Forces Med J India. 2011;67(2):131-137. doi:10.1016/S0377-1237(11)60011-7
  14. Maddry JK, Sessions D, Heard K, Lappan C, McManus J, Bebarta VS. Wartime toxicology: evaluation of a military medical toxicology telemedicine consults service to assist physicians serving overseas and in combat (2005-2012). J Med Toxicol. 2014;10(3):261-265. doi:10.1007/s13181-014-0398-z
  15. Ellis BC, Brown SGA. Management of anaphylaxis in an austere or operational environment. J Spec Oper Med. 2014;14(4):1-5. https://www.ncbi.nlm.nih.gov/pubmed/25399361.
  16. Pearn JH. Bee stings in operational theatres. Mil Med. 1972;137(6):241-242. https://www.ncbi.nlm.nih.gov/pubmed/4625675.
  17. Heiner JD, Bebarta VS, Varney SM, Bothwell JD, Cronin AJ. Clinical effects and antivenom use for snake bite victims treated at three US hospitals in Afghanistan. Wilderness Environ Med. 2013;24(4):412-416. doi:10.1016/j.wem.2013.05.001
  18. Haviv J, Huerta M, Shpilberg O, Klement E, Ash N, Grotto I. Poisonous animal bites in the Israel Defense Forces. Public Health Rev. 1998;26(3):237-245. https://www.ncbi.nlm.nih.gov/pubmed/10444961.
  19. Shiau DT, Sanders JW, Putnam SD, et al. Self-reported incidence of snake, spider, and scorpion encounters among deployed U.S. military in Iraq and Afghanistan. Mil Med. 2007;172(10):1099-1102. doi:10.7205/milmed.172.10.1099
  20. Wilkins D, Burns DS, Wilson D, Warrell DA, Lamb LEM. Snakebites in Africa and Europe: a military perspective and update for contemporary operations. J R Army Med Corps. 2018;164(5):370-379. doi:10.1136/jramc-2017-000883
  21. Cline CR, Goodnight ME. Pit viper envenomation in a military working dog. US Army Med Dep J. January 2013:28-33. https://www.ncbi.nlm.nih.gov/pubmed/23277442.
  22. Murdock RT, White GL Jr, Pedersen DM, DeFaller JM, Snyder CC. Prevention and emergency field management of venomous snakebites during military exercises. Mil Med. 1990;155(12):587-590. https://www.ncbi.nlm.nih.gov/pubmed/2134840.
  23. Field Treatment of Snakebites in the Israel Defense Forces.
  24. Pierson JF. Use of unapproved products, off-label use, and black-box warning... A variation of Newton’s third law or the practical application of the rule of unintended consequences… Considerations in military operational medicine. Journal of Special Operations Medicine Volume. 2007;7:50-60. https://www.jsomonline.org/articles/0704/2007450Pierson.pdf.
  25. Hansen EA, Stein EA, Mader TH, Mazzoli RA. Spitting cobra ophthalmia in United Nations Forces in Somalia. Am J Ophthalmol. 1994;117(5):671. doi:10.1016/s0002-9394(14)70078-9
  26. Mehta SR, Sashindran VK. Clinical Features And Management Of Snake Bite. Armed Forces Med J India. 2002;58(3):247-249. doi:10.1016/S0377-1237(02)80140-X
  27. Sagar A, Joshi DC. First reported case of African Viper bite treated with Indian Polyvalent Anti Snake Venom. Armed Forces Med J India. 2010;66(2):199-200. doi:10.1016/S0377-1237(10)80154-6
  28. Chauhan K, Nayar KR. AN EPIDEMIOLOGICAL STUDY OF SNAKE BITES IN AN AREA IN THE FOOTHILLS OF THE NORTH WESTERN HIMALAYAS. Armed Forces Med J India. 1995;51(4):270-272. doi:10.1016/S0377-1237(17)30990-5
  29. Virmani SK. CARDIAC INVOLVEMENT IN SNAKE BITE. Armed Forces Med J India. 2002;58(2):156-157. doi:10.1016/S0377-1237(02)80054-5
  30. Chen C, Gui L, Kan T, Li S, Qiu C. A Survey of Snakebite Knowledge among Field Forces in China. Int J Environ Res Public Health. 2016;14(1). doi:10.3390/ijerph14010015
  31. Flowers HH, Berlinger FG. The psychological importance of snakes to the combat soldier. Mil Med. 1973;138(3):144-145. https://www.ncbi.nlm.nih.gov/pubmed/4631483.
  32. Berlinger FG, Flowers HH. Some Observations on the Treatment of Snakebites in Vietnam. Mil Med. 1973;138(3):139-143. doi:10.1093/milmed/138.3.139
  33. Heap BJ, Cowan GO. The epidemiology of snake bite presenting to British Military Hospital Dharan during 1989. J R Army Med Corps. 1991;137(3):123-125. doi:10.1136/jramc-137-03-03
  34. Roszko PJD, Kavanaugh MJ, Boese ML, Longwell JJ, Earley AS. Rotational thromboelastometry (ROTEM) guided treatment of an Afghanistan viper envenomation at a NATO military hospital. Clin Toxicol . 2017;55(3):229-230. doi:10.1080/15563650.2016.1263857
  35. Handford C. Case of venom ophthalmia following contact with Naja pallida: the red spitting cobra. J R Army Med Corps. 2018;164(2):124-126. doi:10.1136/jramc-2017-000891
  36. Lavon O, Bentur Y. Poison exposures in young Israeli military personnel: a National Poison Center Data analysis. Clin Toxicol . 2017;55(5):322-325. doi:10.1080/15563650.2016.1278225
  37. Ari AB. Patient with purely extraocular manifestations from a pit viper snakebite (Agkistrodon halys brevicaudus). Mil Med. 2001;166(7):667-669. https://www.ncbi.nlm.nih.gov/pubmed/11469043.
  38. Deshwal R, Gupta V. Krait envenomation disguised as heat exhaustion in a wilderness setting. Wilderness Environ Med. 2015;26(1):102-104. doi:10.1016/j.wem.2014.08.005
  39. Donat N, Masson Y, Villevieille T, et al. A case of combat-related scorpion envenomation in Afghanistan. Mil Med. 2011;176(4):472-474. doi:10.7205/milmed-d-10-00387
  40. Radonić V, Budimir D, Bradarić N, Luksić B, Sapunar D, Vilović K. Envenomation by the horned viper (Vipera ammodytes L.). Mil Med. 1997;162(3):179-182. https://www.ncbi.nlm.nih.gov/pubmed/9121663.
  41. Schäfer CN, Nissen LR, Kofoed LT, Hansen FØ. A suspected case of systemic envenomation syndrome in a soldier returning from Iraq: implications for Special Forces Operations. Mil Med. 2010;175(5):375-378. https://www.ncbi.nlm.nih.gov/pubmed/20486513.
  42. Poyrazoglu Y, Toygar M, Turk Y, Yildirim A, Ozenc S. Pit Viper Envenomation in Military Personnel. TAF Preventive Medicine Bulletin. 2012;11(2):127. doi:10.5455/pmb.1-1328962738
  43. Groshong TD. Scorpion envenomation in eastern Saudi Arabia. Ann Emerg Med. 1993;22(9):1431-1437. doi:10.1016/s0196-0644(05)81992-4
  44. Johnson C, Rimmer J, Mount G, Gurney I, Nicol ED. Challenges of managing snakebite envenomation in a deployed setting. J R Army Med Corps. 2013;159(4):307-311. doi:10.1136/jramc-2013-000047
  45. Dewar C, Meusnier J-G, Larréché S. Envenimation scorpionique chez des militaires français en poste isolé au Nord Mali : à propos de cinq cas. Annales françaises de médecine d’urgence. 2016;6(6):431-434. doi:10.1007/s13341-016-0690-4
  46. Larréché S, Aigle L, Puidupin M, et al. Animaux venimeux terrestres en opérations extérieures: présentation des principaux risques et du Comité technique des envenimations. Médecine et Armées. 2018;46(1):63-72. http://www.ecole-valdegrace.sante.defense.gouv.fr/content/download/7919/85068/file/08%20Larr%C3%A9ch%C3%A9%20S.%20Animaux%20venimeux%20terrestres%20en%20Opex.%20M%C3%A9decine%20et%20Arm%C3%A9es%202018-1-63-72.pdf.
  47. Gutiérrez JM, Rucavado A, Escalante T, et al. Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms. Toxicon. 2018;148:123-131. doi:10.1016/j.toxicon.2018.04.016
  48. Abubakar SB, Habib AG, Mathew J. Amputation and disability following snakebite in Nigeria. Trop Doct. 2010;40(2):114-116. doi:10.1258/td.2009.090266
  49. Baldé MC, Chippaux J-P, Boiro MY, Stock RP, Massougbodji A. Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa. J Venom Anim Toxins Incl Trop Dis. 2013;19(1):6. doi:10.1186/1678-9199-19-6
  50. Erulu VE, Okumu MO, Ochola FO, Gikunju JK. Revered but Poorly Understood: A Case Report of Dendroaspis polylepis (Black Mamba) Envenomation in Watamu, Malindi Kenya, and a Review of the Literature. Trop Med Infect Dis. 2018;3(3). doi:10.3390/tropicalmed3030104
  51. Ranawaka UK, Lalloo DG, de Silva HJ. Neurotoxicity in snakebite--the limits of our knowledge. PLoS Negl Trop Dis. 2013;7(10):e2302. doi:10.1371/journal.pntd.0002302
  52. Halilu S, Iliyasu G, Hamza M, Chippaux J-P, Kuznik A, Habib AG. Snakebite burden in Sub-Saharan Africa: estimates from 41 countries. Toxicon. 2019;159:1-4. doi:10.1016/j.toxicon.2018.12.002
  53. Habib AG, Brown NI. The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon. 2018;150:115-123. doi:10.1016/j.toxicon.2018.05.009
  54. WHO/Regional Office for Africa. Guidelines for the Prevention and Clinical Management of Snakebite in Africa. (Tempowski DJH, ed.). World Health Organization; 2010. https://apps.who.int/iris/bitstream/handle/10665/204458/9789290231684.pdf.
  55. Langley RL. Snakebite during pregnancy: a literature review. Wilderness Environ Med. 2010;21(1):54-60. doi:10.1016/j.wem.2009.12.025
  56. Adewole AA, Ugiagbe OA, Onile TG, et al. Snake bite in third trimester of pregnancy with systemic envenomation and delivery of a live baby in a low resource setting: A case report. Case Rep Womens Health. 2017;16:14-17. doi:10.1016/j.crwh.2017.10.001
  57. Muhammed A, Dalhat MM, Joseph BO, et al. Predictors of depression among patients receiving treatment for snakebite in General Hospital, Kaltungo, Gombe State, Nigeria: August 2015. Int J Ment Health Syst. 2017;11:26. doi:10.1186/s13033-017-0132-8
  58. Williams SS, Wijesinghe CA, Jayamanne SF, et al. Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl Trop Dis. 2011;5(8):e1255. doi:10.1371/journal.pntd.0001255
  59. Hiller K, Jarrod MM, Franke HA, Degan J, Boyer LV, Fox FM. Scorpion antivenom administered by alternative infusions. Ann Emerg Med. 2010;56(3):309-310. doi:10.1016/j.annemergmed.2010.04.007
  60. Williams DJ, Jensen SD, Nimorakiotakis B, Müller R, Winkel KD. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Toxicon. 2007;49(6):780-792. doi:10.1016/j.toxicon.2006.11.026
  61. Thiansookon A, Rojnuckarin P. Low incidence of early reactions to horse-derived F(ab’)(2) antivenom for snakebites in Thailand. Acta Trop. 2008;105(2):203-205. doi:10.1016/j.actatropica.2007.09.007
  62. de Menezes JB Hering SE. . CPA-MM. Immediate hypersensitivity reactions following intravenous use of antivenom sera: predictive value of hypersensitivity skin test. Rev Inst Med Trop Sao Paulo. 1991;33(2):115-122. doi:10.1590/s0036-46651991000200005.
  63. Klaewsongkram J. A role of snake antivenom skin test from the allergist’s point of view. Acta Trop. 2009;109(1):84-85; author reply 86. doi:10.1016/j.actatropica.2008.09.007
  64. Norris RL, Ngo J, Nolan K, Hooker G. Physicians and lay people are unable to apply pressure immobilization properly in a simulated snakebite scenario. Wilderness Environ Med. 2005;16(1):16-21. doi:10.1580/PR12-04.1
  65. O’Connor AD, Ruha A-M, Levine M. Pressure immobilization bandages not indicated in the pre-hospital management of North American snakebites. J Med Toxicol. 2011;7(3):251. doi:10.1007/s13181-011-0163-5
  66. American College of Medical Toxicology, American Academy of Clinical Toxicology, American Association of Poison Control Centers, European Association of Poison Control Centres, International Society of Toxinology, Asia Pacific Association of Medical Toxicology. Pressure immobilization after North American Crotalinae snake envenomation. J Med Toxicol. 2011;7(4):322-323. doi:10.1007/s13181-011-0174-2
  67. Benjamin JM, Chippaux J-P, Jackson K, et al. Differential Diagnosis of an Unusual Snakebite Presentation in Benin: Dry Bite or Envenomation? J Spec Oper Med. 2019;19(2):18-22. https://www.ncbi.nlm.nih.gov/pubmed/31201747.
  68. Watt G, Theakston RDG, Padre L, Laughlin LW, Tuazon ML. Tourniquet Application after Cobra Bite: Delay in the Onset of Neurotoxicity and the Dangers of Sudden Release. Am J Trop Med Hyg. 1988;38(3):618-622. doi:10.4269/ajtmh.1988.38.618
  69. Warrell DA, Davidson NMcD, Greenwood BM, et al. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med. 1977;46(181):33-62. doi:10.1093/oxfordjournals.qjmed.a067493
  70. Benjamin JM, Chippaux J-P, Tamou-Sambo B, Akpakpa OC, Massougbodji A. Successful Management of Two Patients with Intracranial Hemorrhage due to Carpet Viper (Echis ocellatus) Envenomation in a Limited-Resource Environment. Wilderness Environ Med. June 2019. doi:10.1016/j.wem.2019.04.003
  71. Dart RC, Hurlbut KM, Garcia R, Boren J. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996;27(3):321-326. doi:10.1016/s0196-0644(96)70267-6
  72. Rega PP, Bork CE, Burkholder-Allen K, Bisesi MS, Gold JP. Single-Breath-Count Test: An Important Adjunct in the Triaging of Patients in a Mass-Casualty Incident Due to Botulism. Prehosp Disaster Med. 2010;25(3):219-222. doi:10.1017/S1049023X00008062
  73. Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Snake bite in South Asia: a review. PLoS Negl Trop Dis. 2010;4(1):e603. doi:10.1371/journal.pntd.0000603
  74. Gold BS. Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra. Ann Emerg Med. 1996;28(1):87-89. doi:10.1016/s0196-0644(96)70142-7
  75. Winkel KD, Mc Gain F, Nimorakiotakis B, Williams D. The use of anticholinesterase therapy.
  76. Bawaskar HS, Bawaskar PH. Envenoming by the common krait (Bungarus caeruleus) and Asian cobra (Naja naja): clinical manifestations and their management in a rural setting. Wilderness Environ Med. 2004;15(4):257-266. doi:10.1580/1080-6032(2004)015[0257:EBTCKB]2.0.CO;2
  77. WHO/Regional Office for South-East Asia. Guidelines for the Management of Snakebites, 2nd Edition. (Warrell DA, ed.). World Health Organization; 2016.
  78. Benjamin JM, Chippaux J-P, Sambo BT, Massougbodji A. Delayed double reading of whole blood clotting test (WBCT) results at 20 and 30 minutes enhances diagnosis and treatment of viper envenomation. J Venom Anim Toxins Incl Trop Dis. 2018;24:14. doi:10.1186/s40409-018-0151-1
  79. Ogunfowokan O, Jacob DA, Livinus OL. Relationship between bite-to-hospital time and morbidity in victims of carpet viper bite in North-Central Nigeria. West Afr J Med. 2011;30(5):348-353. https://www.ncbi.nlm.nih.gov/pubmed/22752823.
  80. Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP 2nd. Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol. 2002;40(7):911-918. https://www.ncbi.nlm.nih.gov/pubmed/12507061.
  81. Hatten BW, Bueso A, French LK, Hendrickson RG, Horowitz BZ. Envenomation by the Great Lakes Bush Viper (Atheris nitschei). Clin Toxicol . 2013;51(2):114-116. doi:10.3109/15563650.2012.763134
  82. Jeon YJ, Kim JW, Park S, Shin DW. Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study. Acute Crit Care. 2019;34(4):269-275. doi:10.4266/acc.2019.00591
  83. Cumpston KL. Is there a role for fasciotomy in Crotalinae envenomations in North America? Clin Toxicol . 2011;49(5):351-365. doi:10.3109/15563650.2011.597032
  84. Hawkins SC. Wilderness EMS. Lippincott Williams & Wilkins; 2017. https://play.google.com/store/books/details?id=2yQ6DwAAQBAJ.
  85. Tanen DA, Danish DC, Grice GA, Riffenburgh RH, Clark RF. Fasciotomy worsens the amount of myonecrosis in a porcine model of crotaline envenomation. Ann Emerg Med. 2004;44(2):99-104. doi:10.1016/S0196064404000575
  86. Mazer-Amirshahi M, Boutsikaris A, Clancy C. Elevated compartment pressures from copperhead envenomation successfully treated with antivenin. J Emerg Med. 2014;46(1):34-37. doi:10.1016/j.jemermed.2013.05.025
  87. Moore EC, Porter LM, Ruha A-M. Rattlesnake venom-induced recurrent coagulopathy in first trimester pregnant women – Two Cases. Toxicon. 2019;163:8-11. doi:10.1016/j.toxicon.2019.03.006
  88. Diallo B, Keita M, Dicko H, et al. [Recurrent retroperitoneal hematoma due to viperine envenomation: case study]. Pan Afr Med J. 2019;32:70. doi:10.11604/pamj.2019.32.70.17951
  89. Boyer LV, Seifert SA, Clark RF, et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med. 1999;159(7):706-710. doi:10.1001/archinte.159.7.706
  90. Lavonas EJ, Schaeffer TH, Kokko J, Mlynarchek SL, Bogdan GM. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review. BMC Emerg Med. 2009;9:13. doi:10.1186/1471-227X-9-13
  91. Boyer LV, Ruha A-M. Pitviper Envenomation Guidelines Should Address Choice Between FDA-approved Treatments for Cases at Risk of Late Coagulopathy. Wilderness Environ Med. 2016;27(2):341-342. doi:10.1016/j.wem.2015.10.013
  92. Bush SP, Ruha A-M, Seifert SA, et al. Comparison of F(ab’)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol . 2015;53(1):37-45. doi:10.3109/15563650.2014.974263
  93. Gutiérrez JM, León G, Lomonte B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet. 2003;42(8):721-741. doi:10.2165/00003088-200342080-00002
  94. Clark RF, McKinney PE, Chase PB, Walter FG. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med. 2002;39(6):671-676. doi:10.1067/mem.2002.123134
  95. Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001;37(2):181-188. doi:10.1067/mem.2001.113372
  96. Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57(2):128-137.e3. doi:10.1016/j.annemergmed.2010.06.550
  97. Boyer L, Degan J, Ruha A-M, Mallie J, Mangin E, Alagón A. Safety of intravenous equine F(ab’)2: insights following clinical trials involving 1534 recipients of scorpion antivenom. Toxicon. 2013;76:386-393. doi:10.1016/j.toxicon.2013.07.017
  98. de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81(3):446-452. doi:10.1111/bcp.12739
  99. Chippaux JP, Lang J, Eddine SA, et al. Clinical safety of a polyvalent F(ab’)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans R Soc Trop Med Hyg. 1998;92(6):657-662. doi:10.1016/s0035-9203(98)90802-1
  100. Warrell DA, Ormerod LD, Davidson NM. Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. Br Med J. 1975;4(5998):697-700. doi:10.1136/bmj.4.5998.697
  101. Lavonas EJ, Ruha A-M, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2. doi:10.1186/1471-227X-11-2
  102. Gerardo CJ, Quackenbush E, Lewis B, et al. The efficacy of Crotalidae polyvalent immune Fab (Ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial. Ann Emerg Med. 2017;70(2):233-244. https://www.sciencedirect.com/science/article/pii/S0196064417305103.
  103. Gerardo CJ, Vissoci JRN, Evans CS, Simel DL, Lavonas EJ. Does This Patient Have a Severe Snake Envenomation?: The Rational Clinical Examination Systematic Review. JAMA Surg. 2019;154(4):346-354. doi:10.1001/jamasurg.2018.5069
  104. Habib AG, Abubakar SB. Factors affecting snakebite mortality in north-eastern Nigeria. Int Health. 2011;3(1):50-55. doi:10.1016/j.inhe.2010.08.001
  105. Iliyasu G, Tiamiyu AB, Daiyab FM, Tambuwal SH, Habib ZG, Habib AG. Effect of distance and delay in access to care on outcome of snakebite in rural north-eastern Nigeria. Rural Remote Health. 2015;15(4):3496. https://www.ncbi.nlm.nih.gov/pubmed/26590373.
  106. Chippaux J-P, Baldé MC, Sessinou É, Yéro Boiro M, Massougbodji A. [Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea]. Med Sante Trop. 2015;25(1):56-64. doi:10.1684/mst.2014.0413
  107. Agarwal R, Aggarwal AN, Gupta D, Behera D, Jindal SK. Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming. Emerg Med J. 2005;22(6):397-399. doi:10.1136/emj.2004.020727
  108. Alirol E, Sharma SK, Ghimire A, et al. Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal. PLoS Negl Trop Dis. 2017;11(5):e0005612. doi:10.1371/journal.pntd.0005612
  109. Chippaux J-P, Massougbodji A, Stock RP, Alagon A, Investigators of African Antivipmyn in Benin. Clinical trial of an F(ab’)2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg. 2007;77(3):538-546. https://www.ncbi.nlm.nih.gov/pubmed/17827375.
  110. Chippaux J-P, Lang J, Eddine SA, et al. Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. Trans R Soc Trop Med Hyg. 1998;92(6):657-662. doi:10.1016/S0035-9203(98)90802-1
  111. Abubakar IS, Abubakar SB, Habib AG, et al. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis. 2010;4(7):e767. doi:10.1371/journal.pntd.0000767
  112. Sano-Martins IS, Fan HW, Castro SCB, et al. Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Toxicon. 1994;32(9):1045-1050. doi:10.1016/0041-0101(94)90388-3
  113. Gaus DP, Herrera DF, Troya CJ, Guevara AH. Management of snakebite and systemic envenomation in rural Ecuador using the 20-minute whole blood clotting test. Wilderness Environ Med. 2013;24(4):345-350. doi:10.1016/j.wem.2013.08.001
  114. Chippaux JP, Amadi-Eddine S, Fagot P. [Diagnosis and monitoring of hemorrhage due to viper envenomation in the African savanna]. Bull Soc Pathol Exot. 1999;92(2):109-113. https://www.ncbi.nlm.nih.gov/pubmed/10399601.
  115. Madaki JKA, Obilom R, Mandong BM. Clinical Presentation And Outcome Of Snake-Bite Patients At Zamko Comprehensive Health Centre, Langtang, Plateau State. Highland Medical Research Journal. 2004;2(2):61-68. https://www.ajol.info/index.php/hmrj/article/view/33855. Accessed December 29, 2019.
  116. Dsilva AA, Basheer A, Thomas K. Snake envenomation: is the 20 min whole blood clotting test (WBCT20) the optimum test for management? QJM. 2019;112(8):575-579. doi:10.1093/qjmed/hcz077
  117. Ratnayake I, Shihana F, Dissanayake DM, Buckley NA, Maduwage K, Isbister GK. Performance of the 20-minute whole blood clotting test in detecting venom induced consumption coagulopathy from Russell’s viper (Daboia russelii) bites. Thromb Haemost. 2017;117(3):500-507. doi:10.1160/TH16-10-0769
  118. Isbister GK, Maduwage K, Shahmy S, et al. Diagnostic 20-min whole blood clotting test in Russell’s viper envenoming delays antivenom administration. QJM. 2013;106(10):925-932. doi:10.1093/qjmed/hct102
  119. Punguyire D, Iserson KV, Stolz U, Apanga S. Bedside Whole-Blood Clotting Times: Validity after Snakebites. J Emerg Med. 2013;44(3):663-667. doi:10.1016/j.jemermed.2012.07.073
  120. Bawaskar HS, Bawaskar PH. Profile of snakebite envenoming in western Maharashtra, India. Trans R Soc Trop Med Hyg. 2002;96(1):79-84. doi:10.1016/s0035-9203(02)90250-6
  121. Baldé MC, Chippaux J-P, Boiro MY, Stock R, Massougbodji A. [Clinical study of tolerance and effectiveness of a F(ab’)(2) polyvalent antienom for African snake bites in Kindia, Guinea]. Bull Soc Pathol Exot. 2012;105(3):157-161. doi:10.1007/s13149-012-0223-3
  122. Curry S. Rapid Collapse and Anaphylactoid Reactions from Rattlesnake Bites. The Tox and The Hound (EMCrit). https://emcrit.org/toxhound/ff-rapid-collapse-rattlesnake/. Published April 5, 2019.
  123. Chaisakul J, Isbister GK, Kuruppu S, Konstantakopoulos N, Hodgson WC. An examination of cardiovascular collapse induced by eastern brown snake (Pseudonaja textilis) venom. Toxicol Lett. 2013;221(3):205-211. doi:10.1016/j.toxlet.2013.06.235
  124. Kakumanu R, Kemp-Harper BK, Silva A, Kuruppu S, Isbister GK, Hodgson WC. An in vivo examination of the differences between rapid cardiovascular collapse and prolonged hypotension induced by snake venom. Sci Rep. 2019;9(1):20231. doi:10.1038/s41598-019-56643-0
  125. Norris RL, Wilkerson JA, Feldman J. Syncope, massive aspiration, and sudden death following rattlesnake bite. Wilderness Environ Med. 2007;18(3):206-208. doi:10.1580/06-WEME-CR-012R.1
  126. Tilbury CR, Verster J. A fatal bite from the burrowing asp Atractaspis corpulenta (Hallowell 1854). Toxicon. 2016;118:21-26. doi:10.1016/j.toxicon.2016.04.035
  127. Brooks DE, Graeme KA. Airway compromise after first rattlesnake envenomation. Wilderness Environ Med. 2004;15(3):188-193. doi:10.1580/1080-6032(2004)15[188:ACAFRE]2.0.CO;2
  128. Ryan KC, Martin Caravati E. Life-threatening anaphylaxis following envenomation by two different species of Crotalidae. J Wilderness Med. 1994;5(3):263-268. doi:10.1580/0953-9859-5.3.263
  129. Hinze JD, Barker JA, Jones TR, Winn RE. Life-threatening upper airway edema caused by a distal rattlesnake bite. Ann Emerg Med. 2001;38(1):79-82. doi:10.1067/mem.2001.114321
  130. Kerns W 2nd, Tomaszewski C. Airway obstruction following canebrake rattlesnake envenomation. J Emerg Med. 2001;20(4):377-380. https://www.ncbi.nlm.nih.gov/pubmed/11348818.
  131. Johnston MA, Fatovich DM, Haig AD, Daly FFS. Successful resuscitation after cardiac arrest following massive brown snake envenomation. Med J Aust. 2002;177(11-12):646-649. https://www.ncbi.nlm.nih.gov/pubmed/12463988.
  132. Boyd JJ, Agazzi G, Svajda D, Morgan AJ, Ferrandis S, Norris RL. Venomous snakebite in mountainous terrain: prevention and management. Wilderness Environ Med. 2007;18(3):190-202. doi:10.1580/06-WEME-RA-087R.1
  133. Morais V. Antivenom therapy: efficacy of premedication for the prevention of adverse reactions. J Venom Anim Toxins Incl Trop Dis. 2018;24:7. doi:10.1186/s40409-018-0144-0
  134. de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8(5):e1000435. doi:10.1371/journal.pmed.1000435
  135. Premawardhena AP, de Silva CE, Fonseka MMD, Gunatilake SB, de Silva HJ. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999;318(7190):1041-1043. doi:10.1136/bmj.318.7190.1041
  136. Habib AG. Effect of pre-medication on early adverse reactions following antivenom use in snakebite: a systematic review and meta-analysis. Drug Saf. 2011;34(10):869-880. doi:10.2165/11592050-000000000-00000
  137. Dassanayake AS, Karunanayake P, Kasturiratne K, et al. Safety of subcutaneous adrenaline as prophylaxis against acute adverse reactions to anti-venom serum in snakebite. Ceylon Med J. 2011;47(2). https://www.researchgate.net/profile/Anuradha_Dassanayake/publication/11240909_Safety_of_subcutaneous_adrenaline_as_prophylaxis_against_acute_adverse_reactions_to_anti-venom_serum_in_snakebite/links/02e7e52f860d6e1296000000/Safety-of-subcutaneous-adrenaline-as-prophylaxis-against-acute-adverse-reactions-to-anti-venom-serum-in-snakebite.pdf.
  138. Herrera M, Sánchez M, Machado A, et al. Effect of premedication with subcutaneous adrenaline on the pharmacokinetics and immunogenicity of equine whole IgG antivenom in a rabbit model. Biomed Pharmacother. 2017;90:740-743. doi:10.1016/j.biopha.2017.04.039
  139. Choo KJL, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2010;65(10):1205-1211. doi:10.1111/j.1398-9995.2010.02424.x
  140. Stokes S, Hudson S. Managing anaphylaxis in a jungle environment. Wilderness Environ Med. 2012;23(1):51-55. doi:10.1016/j.wem.2011.12.002
  141. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-873. doi:10.1067/mai.2001.119409
  142. Duvauchelle T, Robert P, Donazzolo Y, et al. Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers. J Allergy Clin Immunol Pract. 2018;6(4):1257-1263. doi:10.1016/j.jaip.2017.09.021
  143. Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76-80. doi:10.1016/j.jaip.2014.06.007
  144. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101(1 Pt 1):33-37. doi:10.1016/S0091-6749(98)70190-3
  145. Coralic Z. The Dirty Epi Drip: IV Epinephrine When You Need It. ALiEM. https://www.aliem.com/2013/06/dirtyepi/. Published June 27, 2013.
  146. Einterz EM, Bates ME. Snakebite in northern Cameroon: 134 victims of bites by the saw-scaled or carpet viper, Echis ocellatus. Trans R Soc Trop Med Hyg. 2003;97(6):693-696. doi:10.1016/s0035-9203(03)80105-0
  147. Chippaux J-P. Snake Venoms and Envenomations. Krieger Publishing Company; 2006.
  148. Bush SP. Snakebite suction devices Do not remove venom: they just suck. Ann Emerg Med. 2004;43(2):187-188. doi:10.1016/j.annemergmed.2003.10.031
  149. Parker-Cote J, Meggs WJ. First Aid and Pre-Hospital Management of Venomous Snakebites. Trop Med Infect Dis. 2018;3(2). doi:10.3390/tropicalmed3020045 Alberts MB, Shalit M, LoGalbo F. Suction for venomous snakebite: A study of “mock venom” extraction in a human model. Ann Emerg Med. 2004;43(2):181-186. doi:10.1016/S0196-0644(03)00813-8
  150. Leopold RS, Huber GS. Ineffectiveness of suction in removing snake venom from open wounds. U S Armed Forces Med J. 1960;11:682-685. https://www.ncbi.nlm.nih.gov/pubmed/14415856.
  151. Bush SP, Hegewald KG, Green SM, Cardwell MD, Hayes WK. Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. Wilderness Environ Med. 2000;11(3):180-188. doi:10.1580/1080-6032(2000)011[0180:eoanpv]2.3.co;2
  152. Panagides N, Jackson TNW, Ikonomopoulou MP, et al. How the Cobra Got Its Flesh-Eating Venom: Cytotoxicity as a Defensive Innovation and Its Co-Evolution with Hooding, Aposematic Marking, and Spitting. Toxins . 2017;9(3). doi:10.3390/toxins9030103
  153. Bittenbinder MA, Zdenek CN, Op den Brouw B, et al. Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib). Toxins . 2018;10(12). doi:10.3390/toxins10120516
  154. Spawls S, Branch B. The Dangerous Snakes of Africa. Ralph Curtis Pub; 1995.
  155. Chu ER, Weinstein SA, White J, Warrell DA. Venom ophthalmia caused by venoms of spitting elapid and other snakes: Report of ten cases with review of epidemiology, clinical features, pathophysiology and management. Toxicon. 2010;56(3):259-272. doi:10.1016/j.toxicon.2010.02.023
  156. Warrell DA, Ormerod LD. Snake venom ophthalmia and blindness caused by the spitting cobra (Naja nigricollis) in Nigeria. Am J Trop Med Hyg. 1976;25(3):525-529. doi:10.4269/ajtmh.1976.25.525
  157. Hoffman J. Venom ophthalmia from Naja mossambica in KwaZulu Natal, South Africa: a reminder to all that for ocular chemical injury, dilution is the solution. Trop Doct. 2015;45(4):250-251. doi:10.1177/0049475514564695
  158. Chu ERL, White J, Weinstein S. Is there any role for intravenous antivenom for snake venom ophthalmia? J Emerg Med. 2010;39(5):659-660; author reply 660-661. doi:10.1016/j.jemermed.2009.06.128
  159. WHO Expert Committee on Biological Standardization. WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. World Health Organization; 2010.
  160. Lam A, Cabral M, Touré A, et al. Évaluation de l’efficacité et la tolérance de Inoserp® Panafricain au Sénégal. Toxicologie Analytique et Clinique. 2019;31(1):18-29. doi:10.1016/j.toxac.2018.12.008
  161. Coulibaly SK, Diallo T, Diara A, Soulaymani A, Maiga AI. Sérothérapie antivenimeuse au Mali : expérience du centre de santé de référence de Kati région de Koulikoro. Toxicologie Analytique et Clinique. 2018;30(3):165. doi:10.1016/j.toxac.2018.07.094
  162. Baldé MC. Defis et perspectives de la prise en charge des envenimations par elapids en Guinee. A` propos d’une patiente traitee par Inoserp Pan-Africa. In: One Health, Vers Une Seule Santé. Med Sante Trop; :446. doi:10.1684/mst.2019.0908
  163. Lam A, Cabral M, Touré A, Fall M, Diouf A, Chippaux JP. Evaluation de la prise en charge des envenimations au Sénégal : étude clinique de l’Inoserp® Panafricain. Toxicologie Analytique et Clinique. 2018;30(3):165-166. doi:10.1016/j.toxac.2018.07.095
  164. Chafiq F, Rhalem N, Hmimou R, et al. Snakebite and use of three antivenoms in Morocco: FAV-Afrique (R), Favirept (R) and Inoserp (R) MENA. In: CLINICAL TOXICOLOGY. Vol 54. TAYLOR & FRANCIS LTD 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON …; 2016:513-513.
  165. Chafiq F, Elkarimi ME, Rhalem N, et al. Assessment of Use of Inoserp MENA in the management of snake envenomation in Morocco. In: Toxinology in the 21st Century: Public Health Impact from Basic, Translational and Clinical Sciences.
  166. Chafiq F. Centre Antipoison du Maroc: Rapports de toxicovigilance sur les morsures de serpent au Maroc en 2015. Toxicologie Maroc. 12-2015;27(4):15.
  167. Chafiq F. Centre Antipoison du Maroc: Rapports de toxicovigilance sur les morsures de serpent au Maroc en 2016. Toxicologie Maroc. 12-2015;27(4):13.
  168. Chafiq F. Centre Antipoison du Maroc: Rapports de toxicovigilance sur les morsures de serpent au Maroc en 2017. Toxicologie Maroc. 12-2017;35(4):15.
  169. Chafiq F. Centre Antipoison du Maroc: Rapports de toxicovigilance sur les morsures de serpent au Maroc en 2018. Toxicologie Maroc. 6-2015;41(2):15.
  170. Chafiq F, Hmimou R, Rhalem N, Soulaymani A, Mokhtari A, Soulaymani Bencheikh R. Caractéristiques épidémiologiques des morsures de serpent notifiées au centre antipoison et de pharmacovigilance du Maroc. Année 2016. Toxicologie Analytique et Clinique. 2018;30(3):175-176. doi:10.1016/j.toxac.2018.07.042
  171. Badr A, Abderrahman E, Hassan A, Mina AE, Rachid E, Yassir B. Epidemiological profile of snakebites cases recorded at the 3rd military hospital laayoune morocco between 2011 and 2017. Research Journal of Pharmacy and Technology. 2018;11(5):1752-1756. http://search.proquest.com/openview/73f63493507471f15363286e5da163f2/1?pq-origsite=gscholar&cbl=1096441.
  172. Krüger HJ, Lemke FG. Fatal Boomslang bite in the Northern Cape. Afr J Emerg Med. 2019;9(1):53-55. doi:10.1016/j.afjem.2018.12.006
  173. Moran NF, Newman WJ, Theakston RD, Warrell DA, Wilkinson D. High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom. Trans R Soc Trop Med Hyg. 1998;92(1):69-70. doi:10.1016/s0035-9203(98)90959-2
  174. Potet J, Smith J, McIver L. Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial. PLoS Negl Trop Dis. 2019;13(6):e0007551. doi:10.1371/journal.pntd.0007551
  175. Blaylock R. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa. Toxicon. 2004;43(2):159-166. doi:10.1016/j.toxicon.2003.11.019
  176. Wood D, Webb C, DeMeyer J. Severe snakebites in northern KwaZulu-Natal: treatment modalities and outcomes. S Afr Med J. 2009;99(11):814-818. https://www.ncbi.nlm.nih.gov/pubmed/20218483.
  177. Yates VM, Lebas E, Orpiay R, Bale BJ. Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania. Ann Trop Med Parasitol. 2010;104(5):439-448. doi:10.1179/136485910X12743554760306
  178. McNally SL, Reitz CJ. Victims of snakebite. A 5-year study at Shongwe Hospital, Kangwane, 1978-1982. S Afr Med J. 1987;72(12):855-860. https://www.ncbi.nlm.nih.gov/pubmed/3321484.
  179. Wilkinson D. Retrospective analysis of snakebite at a rural hospital in Zululand. S Afr Med J. 1994;84(12):844-847. https://www.ncbi.nlm.nih.gov/pubmed/7570235.
  180. Mahaba HM. Snakebite: epidemiology, prevention, clinical presentation and management. Ann Saudi Med. 2000;20(1):66-68. doi:10.5144/0256-4947.2000.66
  181. Al-Sadoon MK. Snake bite envenomation in Riyadh province of Saudi Arabia over the period (2005-2010). Saudi J Biol Sci. 2015;22(2):198-203. doi:10.1016/j.sjbs.2014.09.008
  182. Kingston Michael E. Management of Snake Bite in Saudi Arabia. Ann Saudi Med. 1981;1(2):87-94. doi:10.5144/0256-4947.1981.87
  183. AlTamimi A, Malhis NK, Khojah NM, Manea SA, AlTamimi A, AlShammary SA. Antidote Availability in Saudi Arabia Hospitals in the Riyadh Province. Basic Clin Pharmacol Toxicol. 2018;122(2):288-292. doi:10.1111/bcpt.12897
  184. al Harbi N. Epidemiological and clinical differences of snake bites among children and adults in south western Saudi Arabia. J Accid Emerg Med. 1999;16(6):428-430. doi:10.1136/emj.16.6.428
  185. Malik GM. Snake bites in adults from the Asir region of southern Saudi Arabia. Am J Trop Med Hyg. 1995;52(4):314-317. doi:10.4269/ajtmh.1995.52.314
  186. Fung HT, Lam KK, Kam CW. Efficacy and Safety of Snake Antivenom Therapy: Experience of a Regional Hospital. Hong Kong Journal of Emergency Medicine. 2006;13(2):70-78. doi:10.1177/102490790601300209
  187. Mong R, Ng VCH, Tse ML. Safety profile of snake antivenom (use) in Hong Kong--a review of 191 cases from 2008 to 2015. Clin Toxicol. 2017;55(10):1066-1071. https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1334916.
  188. MANUFACTURE AND APPLICATION OF Agkistrodon halys ANTIVENIN. She Zhi. February 1991. http://en.cnki.com.cn/Article_en/CJFDTotal-SZZZ199102003.htm.
  189. Fung HT, Yung WH, Crow P, et al. Green pit viper antivenom from Thailand and Agkistrodon halys antivenom from China compared in treating Cryptelytrops albolabris envenomation of mice. Hong Kong Med J. 2012;18(1):40-45. https://www.ncbi.nlm.nih.gov/pubmed/22302910.
  190. Lam SK, Yip SF, Crow P, et al. Comparison of green pit viper and Agkistrodon halys antivenom in inhibition of coagulopathy due to Trimeresurus albolabris venom: an in-vitro study using human plasma. Hong Kong Med J. 2017;23(1):13-18. doi:10.12809/hkmj154617
  191. Monzavi SM, Salarian AA, Khoshdel AR, Dadpour B, Afshari R. Effectiveness of A Clinical Protocol Implemented To Standardize Snakebite Management In Iran: Initial Evaluation. Wilderness Environ Med. 2015;26(2):115-123. doi:10.1016/j.wem.2014.09.011
  192. Dadpour B, Shafahi A, Monzavi SM, Zavar A, Afshari R, Khoshdel AR. Snakebite prognostic factors: Leading factors of weak therapeutic response following snakebite envenomation. Asia pacific journal of medical toxicology. 2012;1(1):27-33. http://apjmt.mums.ac.ir/m/article_42.html.
  193. Dehghani R, Dadpour B, Mehrpour O. Epidemiological profile of snakebite in Iran, 2009-2010 based on information of Ministry of Health and Medical Education. International journal of medical toxicology and forensic medicine. 2014;4(2):33-41. https://www.researchgate.net/profile/Rouhullah_Dehghani/publication/287253083_Epidemiological_profile_of_snake_bite_in_Iran_2009-2010_based_on_information_of_Ministry_of_Health_and_Medical_Education/links/56af14be08ae43a3980f69e5.pdf.
  194. Rahmani AH, Jalali A, Alemzadeh-Ansari MH, Tafazoli M, Rahim F. Dosage comparison of snake anti-venomon coagulopathy. Iran J Pharm Res. 2014;13(1):283-289. https://www.ncbi.nlm.nih.gov/pubmed/24734082.
  195. Eslamian L, Mobaiyen H, Bayat-Makoo Z. Snake bite in Northwest Iran: A retrospective study. J Anal Res Clin. 2016. https://journals.tbzmed.ac.ir/JARCM/GetFile/jarcm_2007_20160329225109.
  196. Dehghani R, Fathi B, Shahi MP, Jazayeri M. Ten years of snakebites in Iran. Toxicon. 2014;90:291-298. doi:10.1016/j.toxicon.2014.08.063
  197. Monzavi SM, Dadpour B, Afshari R. Snakebite management in Iran: Devising a protocol. J Res Med Sci. 2014;19(2):153-163. https://www.ncbi.nlm.nih.gov/pubmed/24778670.
  198. Dehghani R, Mehrpour O, Shahi MP, et al. Epidemiology of venomous and semi-venomous snakebites (Ophidia: Viperidae, Colubridae) in the Kashan city of the Isfahan province in Central Iran. J Res Med Sci. 2014;19(1):33-40. https://www.ncbi.nlm.nih.gov/pubmed/24672563.
  199. Lamb T, de Haro L, Lonati D, Brvar M, Eddleston M. Antivenom for European Vipera species envenoming. Clin Toxicol . 2017;55(6):557-568. doi:10.1080/15563650.2017.1300261
  200. Haro L de, de Haro L, Lang J, et al. Envenimations par vipères européennes. Étude multicentrique de tolérance du ViperfavTM, nouvel antivenin par voie intraveineuse. Annales Françaises d’Anesthésie et de Réanimation. 1998;17(7):681-687. doi:10.1016/s0750-7658(98)80105-6
  201. De Haro L, Lang J, Bedry R, et al. Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom. In: Annales Francaises D’anesthesie et de Reanimation. Vol 17. ; 1998:681-687. https://europepmc.org/article/med/9750806.
  202. Kurtović T, Brvar M, Grenc D, Lang Balija M, Križaj I, Halassy B. A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation. Toxins . 2016;8(8). doi:10.3390/toxins8080244
  203. Boels D, Hamel JF, Le Roux G, et al. Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav® and Viperatab®. Clin Toxicol . March 2020:1-8. doi:10.1080/15563650.2020.1726377
  204. de Haro L, Choumet V, Robbe-Vincent A, Saliou B, Vaili M, Bon C. Vipers with neurotoxic venom in southeastern France: effectiveness of the polyvalent antivenom Viperfav* for the treatment of envenomed patients. Journal of Toxicology-Clinical Toxicology. 1999;37(3):389-390.
  205. Boels D, Hamel JF, Bretaudeau Deguigne M, Harry P. European viper envenomings: Assessment of ViperfavTM and other symptomatic treatments. Clin Toxicol . 2012;50(3):189-196. doi:10.3109/15563650.2012.660695
  206. Brvar M, Kurtović T, Grenc D, Lang Balija M, Križaj I, Halassy B. Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation. Clin Toxicol . 2017;55(4):241-248. doi:10.1080/15563650.2016.1277235
  207. Casewell NR, Al-Abdulla I, Smith D, Coxon R, Landon J. Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb. Toxins . 2014;6(8):2471-2482. doi:10.3390/toxins6082471
  208. Kurtović T, Brvar M, Grenc D, Balija ML, Križaj I, Halassy B. Vipera ammodites bites treated with antivenom ViperaTAb®: a case series and pharmacokinetic evaluation. In: 2016 Annual Meeting of the Croatian Immunological Society. ; 2016. https://pdfs.semanticscholar.org/0170/0069102950f36c1c575a00191c46977dd091.pdf.
  209. Debono J, Bos MHA, Frank N, Fry B. Clinical implications of differential antivenom efficacy in neutralising coagulotoxicity produced by venoms from species within the arboreal viperid snake genus Trimeresurus. Toxicol Lett. September 2019. doi:10.1016/j.toxlet.2019.09.003
  210. Leong PK, Tan CH, Sim SM, et al. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom). Acta Trop. 2014;132:7-14. doi:10.1016/j.actatropica.2013.12.015
  211. Tan CH, Liew JL, Tan NH, et al. Cross reactivity and lethality neutralization of venoms of Indonesian Trimeresurus complex species by Thai Green Pit Viper Antivenom. Toxicon. 2017;140:32-37. doi:10.1016/j.toxicon.2017.10.014
  212. Leong PK, Sim SM, Fung SY, Sumana K, Sitprija V, Tan NH. Cross neutralization of Afro-Asian cobra and Asian krait venoms by a Thai polyvalent snake antivenom (Neuro Polyvalent Snake Antivenom). PLoS Negl Trop Dis. 2012;6(6):e1672. doi:10.1371/journal.pntd.0001672
  213. Silva A, Hodgson WC, Isbister GK. Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms. Toxins . 2016;8(10). doi:10.3390/toxins8100302
  214. Leong PK, Fung SY, Tan CH, Sim SM, Tan NH. Immunological cross-reactivity and neutralization of the principal toxins of Naja sumatrana and related cobra venoms by a Thai polyvalent antivenom (Neuro Polyvalent Snake Antivenom). Acta Trop. 2015;149:86-93. doi:10.1016/j.actatropica.2015.05.020
  215. Chen JC, Bullard MJ, Chiu TF, Ng CJ, Liaw SJ. Risk of immediate effects from F(ab)2 bivalent antivenin in Taiwan. Wilderness Environ Med. 2000;11(3):163-167. doi:10.1580/1080-6032(2000)011[0163:roieff]2.3.co;2
  216. Mao Y-C, Hung D-Z. Management of Snake Envenomation in Taiwan. Clinical Toxinology in Asia Pacific and Africa. 2015:23-52. doi:10.1007/978-94-007-6386-9_43
  217. Chen JC, Liaw SJ, Bullard MJ, Chiu TF. Treatment of poisonous snakebites in northern Taiwan. J Formos Med Assoc. 2000;99(2):135-139. https://www.ncbi.nlm.nih.gov/pubmed/10770028.
  218. Liu C-C, You C-H, Wang P-J, et al. Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches. PLoS Negl Trop Dis. 2017;11(12):e0006138. doi:10.1371/journal.pntd.0006138
  219. Lin C-C, Chaou C-H, Tseng C-Y. An investigation of snakebite antivenom usage in Taiwan. J Formos Med Assoc. 2016;115(8):672-677. doi:10.1016/j.jfma.2015.07.006
  220. Chang K-P, Lai C-S, Lin S-D. Management of poisonous snake bites in southern Taiwan. Kaohsiung J Med Sci. 2007;23(10):511-518. doi:10.1016/S1607-551X(08)70009-3
  221. Ho C-H, Mao Y-C, Tsai Y-D, et al. Descriptive study of snakebite patients in Northern Taiwan: 2009 to 2016. J Med Sci . 2019;39(3):114. doi:10.4103/jmedsci.jmedsci_68_18
  222. Mao Y-C, Hung D-Z. Epidemiology of snake envenomation in Taiwan. In: Toxinology. Springer, Dordrecht; 2014:1-17. http://link-springer-com-443.webvpn.fjmu.edu.cn/content/pdf/10.1007%2F978-94-007-6288-6_45-1.pdf.
  223. Hsieh Y-H, Hsueh J-H, Liu W-C, et al. Contributing Factors for Complications and Outcomes in Patients With Snakebite: Experience in a Medical Center in Southern Taiwan. Ann Plast Surg. 2017;78(3 Suppl 2):S32-S36. doi:10.1097/SAP.0000000000001002
  224. Tomari T. An epidemiological study of the occurrence of habu snake bite on the Amami Islands, Japan. Int J Epidemiol. 1987;16(3):451-461. doi:10.1093/ije/16.3.451
  225. Yasunaga H, Horiguchi H, Kuwabara K, Hashimoto H, Matsuda S. Short report: Venomous snake bites in Japan. Am J Trop Med Hyg. 2011;84(1):135-136. doi:10.4269/ajtmh.2011.10-0403
  226. Hifumi T, Sakai A, Kondo Y, et al. Venomous snake bites: clinical diagnosis and treatment. J Intensive Care Med. 2015;3(1):16. doi:10.1186/s40560-015-0081-8
  227. Chiba T, Koga H, Kimura N, et al. Clinical Condition and Management of 114 Mamushi (Gloydius blomhoffii) Bites in a General Hospital in Japan. Intern Med. 2018;57(8):1075-1080. doi:10.2169/internalmedicine.9409-17
  228. Fukuda T, Iwaki M, Hong SH, et al. Standardization of regional reference for mamushi (Gloydius blomhoffii) antivenom in Japan, Korea, and China. Jpn J Infect Dis. 2006;59(1):20-24. https://www.ncbi.nlm.nih.gov/pubmed/16495629. Min YG, Ham SH, Jung YS, Choi S. Gaboon viper envenomation: An unexpected injury by non-indigenous snake in South Korea. Turk J Emerg Med. 2018;18(2):75-77. doi:10.1016/j.tjem.2018.04.003
  229. Senek MZF, Kong SY, Shin SD, Sun KM, Kim J, Ro YS. Epidemiological profile and outcomes of snakebite injuries treated in emergency departments in South Korea, 2011-2016: a descriptive study. Trans R Soc Trop Med Hyg. 2019;113(10):590-598. doi:10.1093/trstmh/trz050
  230. Kim ES, Choi WJ. Clinical review of venomous snake bite. J Korean Surg Soc. 2000;59(4):433-440. https://www.komci.org/GSResult.php?RID=0037JKSS%2F2000.59.4.433&DT=6.
  231. Lim H, Kang HG, Kim KH. Antivenom for snake bite in Korea. Journal of the Korean Medical Association/Taehan Uisa Hyophoe Chi. 2013;56(12). http://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=19758456&AN=97769554&h=aCL3DOIU4Hd42wlqYcgdgZj%2FBGL85TNYqaRzpVEugU8VMNFsJPUh89ow7KIxuquHIM1uSTGZjlV9DyrrRuZQxw%3D%3D&crl=c.
  232. Rha JH, Kwon SM, Oh JR, Han BK, Lee KH, Kim JH. Snakebite in Korea: A Guideline to Primary Surgical Management. Yonsei Med J. 2015;56(5):1443-1448. doi:10.3349/ymj.2015.56.5.1443
  233. Kanaan NC, Ray J, Stewart M, et al. Wilderness Medical Society Practice Guidelines for the Treatment of Pitviper Envenomations in the United States and Canada. Wilderness Environ Med. 2015;26(4):472-487. doi:10.1016/j.wem.2015.05.007
  234. Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002;40(6):619-624. doi:10.1067/mem.2002.129939
  235. Curran-Sills G, Kroeker J. Venomous Snakebites in Canada: A National Review of Patient Epidemiology and Antivenom Usage. Wilderness Environ Med. 2018;29(4):437-445. doi:10.1016/j.wem.2018.06.005
  236. Wood A, Schauben J, Thundiyil J, et al. Review of Eastern coral snake (Micrurus fulvius fulvius) exposures managed by the Florida Poison Information Center Network: 1998-2010. Clin Toxicol . 2013;51(8):783-788. doi:10.3109/15563650.2013.828841
  237. Otero-Patiño R, Silva-Haad JJ, Acevedo MJB, et al. Accidente bothrópico en Colombia: estudio multicéntrico de la eficacia seguridad de Antivipmyn-Tri®, un antiveneno polivalente producido en México. Iatreia. 2007;20(3):244-262. https://www.redalyc.org/articulo.oa?id=180513858002.
  238. Resiere D, Villalta M, Arias AS, et al. Snakebite envenoming in French Guiana: Assessment of the preclinical efficacy against the venom of Bothrops atrox of two polyspecific antivenoms. Toxicon. 2020;173:1-4. doi:10.1016/j.toxicon.2019.11.001
  239. Baum RA, Bronner J, Akpunonu PDS, Plott J, Bailey AM, Keyler DE. Crotalus durissus terrificus (viperidae; crotalinae) envenomation: Respiratory failure and treatment with antivipmyn TRI® antivenom. Toxicon. 2019;163:32-35. doi:10.1016/j.toxicon.2019.03.009
  240. Williams KL, Woslager M, Garland SL, Barton RP, Banner W. Use of polyvalent equine anti-viper serum to treat delayed coagulopathy due to suspected Sistrurus miliarius streckeri envenomation in two children. Clin Toxicol . 2017;55(5):326-331. doi:10.1080/15563650.2017.1284334
  241. Baum RA, Bronner J, Akpunonu PDS, Keyler DE. Crotalus durissus terrificus (Viperidae; Crotalinae) envenomation and treatment with Antivipmyn TRI® antivenom. Toxicon. 2018;150:328.
  242. Yang DC, Dobson J, Cochran C, et al. The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom. Neurotoxicity Research. 2017;32(3):487-495. doi:10.1007/s12640-017-9771-4
  243. de Roodt AR, Paniagua-Solis JF, Dolab JA, et al. Effectiveness of two common antivenoms for North, Central, and South American Micrurus envenomations. J Toxicol Clin Toxicol. 2004;42(2):171-178. doi:10.1081/clt-120030943
  244. Pérez ML, Fox K, Schaer M. A retrospective evaluation of coral snake envenomation in dogs and cats: 20 cases (1996--2011). J Vet Emerg Crit Care . 2012;22(6):682-689. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-4431.2012.00806.x.
  245. Sánchez EE, Lopez-Johnston JC, Rodríguez-Acosta A, Pérez JC. Neutralization of two North American coral snake venoms with United States and Mexican antivenoms. Toxicon. 2008;51(2):297-303. doi:10.1016/j.toxicon.2007.10.004
  246. Castillo-Beltrán MC, Hurtado-Gómez JP, Corredor-Espinel V, Ruiz-Gómez FJ. A polyvalent coral snake antivenom with broad neutralization capacity. PLoS Negl Trop Dis. 2019;13(3):e0007250. doi:10.1371/journal.pntd.0007250